BICX - BioCorRx Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue657.271701.772924.7321,170.922
Cost of Revenue323.608175.43151.97220.959
Gross Profit333.663526.342772.762949.963
Operating Expenses
Research Development450.722450.722450.722450.722
Selling General and Administrative2,739.9672,545.3112,125.8823,867.047
Non Recurring----
Others----
Total Operating Expenses3,548.1852,750.9892,402.9224,223.497
Operating Income or Loss-2,890.914-2,049.217-1,478.19-3,052.575
Income from Continuing Operations
Total Other Income/Expenses Net-26,814.755-3,854.765-3,187.8-75.205
Earnings Before Interest and Taxes-2,890.914-2,049.217-1,478.19-3,052.575
Interest Expense-11,148.525-1,048.013-377.087-352.799
Income Before Tax-29,705.669-5,903.982-4,665.99-3,127.78
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-29,705.669-5,903.982-4,665.99-3,127.78
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-29,705.669-5,903.982-4,665.99-3,127.78
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-29,705.669-5,903.982-4,665.99-3,127.78